KILNER CAPITAL ADVISORS, LLC
CIK
2109522
Location
GAITHERSBURG, MD
Portfolio Value
Micro
$1,094,906
Diversification
Highly concentrated
Filing Date
Dec 31, 2025
Global Rank
#8,349
/ 8,420
Top Industry
Information Technology Services
71.6%
3Y Alpha vs SPY
-23.7%
Period ended 6 months ago
Filed Feb 11, 2026 · 4mo
Clone Performance
Feb 2026–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+2.2%
SPY
+9.1%
Annualised alpha
-23.4%
Max drawdown
−16.6%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
2 positions · as of Dec 31, 2025Top Position
71.6%
of portfolio value
Top 5
100.0%
of portfolio value
Top 10
100.0%
of portfolio value
HHI
5,929
Highly concentrated
Sector Breakdown
As of Dec 31, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 71.6% | $783,475 |
| Healthcare | 28.4% | $311,431 |
2 positions ·
$1,094,906 total
· as of Dec 31, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| IBM |
International Business Machines Corp
Technology
|
First | 2,645 | $783,475 | 71.56% | |
| ABBV |
AbbVie Inc.
Healthcare
|
First | 1,363 | $311,431 | 28.44% |